IL1B and neoplasm: Studies recently published by Patrussi et al. and Reboldi et al. showed that glycerophosphoinositols and 25-hydroxycholesterol activate T cells and host immune responses by upregulating IL-1β, which has a well-characterized role in tumor inflammation52,53.